R1 RCM Inc.
RCM
주식 순위
#3054
R1 RCM Inc. leverages technology to provide solutions that both optimize the... R1 RCM Inc. leverages technology to provide solutions that both optimize the patient experience and bolster the financial performance of hospitals, health systems, and medical groups. Its core offering is comprehensive revenue cycle management (RCM), meticulously designed to address the entire spectrum of financial complexities faced by healthcare providers. Beyond this holistic approach, R1 RCM also delivers flexible, specialized solutions. These encompass physician advisory services, guiding healthcare organizations on compliant classification of hospital visits (in-patient versus out-patient observation) for billing purposes. Additional modular services include: Practice management: Offering administrative and operational support to streamline patient care, alongside outsourcing of non-essential functions. Revenue integrity: Encompassing critical elements like accurate charge capture, meticulous maintenance of the charge description master, and strategic pricing services. Coding management: Featuring business intelligence and analytical insights, human capital management, robust accountability frameworks, and quality assurance programs. Patient experience enhancements. Business office support. Furthermore, the company provides cloud-based (SaaS) platforms for scheduling and improving patient access. R1 RCM Inc. was established in 2003 and is headquartered in Murray, Utah.
주가
$14.31
마지막 동기화: 2024-11-20
시가총액
$5.97B
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 R1 RCM Inc. (RCM)
카테고리
Healthcare
R1 RCM Inc. (RCM)의 발행 주식 수
September 2024 기준 발행 주식 수: 422.10M
R1 RCM Inc.의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 422.10M입니다. December 2022 말 기준 회사는 352.34M주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
R1 RCM Inc. (RCM)의 발행 주식 수 기록 (2007 ~ 2026)
매년 말 기준 발행 주식 수
| 연도 | 발행 주식 수 | 변화 |
|---|---|---|
| 2026 (TTM) | 422.10M | 0.84% |
| 2023 | 418.59M | 18.80% |
| 2022 | 352.34M | 32.37% |
| 2021 | 266.18M | 130.00% |
| 2020 | 115.73M | 3.79% |
| 2019 | 111.51M | 3.89% |
| 2018 | 107.33M | 5.23% |
| 2017 | 102.00M | 1.84% |
| 2016 | 100.16M | 3.46% |
| 2015 | 96.81M | 1.09% |
| 2014 | 95.76M | 0.08% |
| 2013 | 95.69M | -2.96% |
| 2012 | 98.60M | 1.69% |
| 2011 | 96.96M | 37.09% |
| 2010 | 70.73M | 92.60% |
| 2009 | 36.73M | -0.59% |
| 2008 | 36.94M | 0.00% |
| 2007 | 36.94M | 0.00% |
유사 기업 또는 경쟁사의 발행 주식 수
| 회사 | 발행 주식 수 | 차이 | 국가 |
|---|---|---|---|
| 453.00M | 7.32% |
US
|
|
| 104.47M | -75.25% |
AU
|
|
| 205.38M | -51.34% |
US
|
|
| 179.92M | -57.38% |
US
|
|
| 129.98M | -69.21% |
US
|
